Literature DB >> 12126481

Growth inhibition by the muscarinic M(3) acetylcholine receptor: evidence for p21(Cip1/Waf1) involvement in G(1) arrest.

Drew Burdon1, Rajnikant Patel, R A John Challiss, Jonathan L Blank.   

Abstract

We have assessed the growth response of Chinese-hamster ovary (CHO) cells to activation of recombinantly expressed G-protein-coupled muscarinic M(2) or M(3) acetylcholine receptors (AChRs). We show that activation of these receptors leads to divergent growth responses: M(2) AChR activation causes an increase in DNA synthesis, whereas M(3) AChR activation causes a dramatic decrease in DNA synthesis. We have characterized the M(3) AChR-mediated growth inhibition and show that it involves a G(1) phase cell-cycle arrest. Further analysis of this arrest indicates that it involves an increase in expression of the cyclin-dependent kinase (CDK) inhibitor, p21(Cip1/Waf1) (where Cip1 is CDK-interacting protein 1 and Waf1 is wild-type p53-associated fragment 1), in response to M(3) AChR activation. This increase in protein expression leads to an increase in p21(Cip1/Waf1) association with CDK2, a decrease in CDK2 activity and an accumulation of hypophosphorylated retinoblastoma protein. The increased p21(Cip1/Waf1) expression is due, at least in part, to an increase in p21(Cip1/Waf1) mRNA, and receptor-mediated changes in phosphorylation of c-Jun provide a mechanism to account for this p21(Cip1/Waf1) transcriptional regulation. Evaluation of the extracellular signal-regulated protein kinase and c-Jun N-terminal kinase activities has shown striking differences in the profiles of activation of these mitogen-activated protein kinases by the M(2) and M(3) AChRs, and their potential involvement in mediating growth arrest by the M(3) AChR is discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12126481      PMCID: PMC1222904          DOI: 10.1042/BJ20020446

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  44 in total

1.  High-intensity p38 kinase activity is critical for p21(cip1) induction and the antiproliferative function of G(i) protein-coupled receptors.

Authors:  F Alderton; P P Humphrey; L A Sellers
Journal:  Mol Pharmacol       Date:  2001-05       Impact factor: 4.436

Review 2.  Rb function in cell-cycle regulation and apoptosis.

Authors:  J W Harbour; D C Dean
Journal:  Nat Cell Biol       Date:  2000-04       Impact factor: 28.824

Review 3.  The regulation of E2F by pRB-family proteins.

Authors:  N Dyson
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

4.  5-hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways.

Authors:  C G Nebigil; J M Launay; P Hickel; C Tournois; L Maroteaux
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

5.  TGF-beta-induced cell-cycle arrest through the p21(WAF1/CIP1)-G1 cyclin/Cdks-p130 pathway in gastric-carcinoma cells.

Authors:  Y D Yoo; J Y Choi; S J Lee; J S Kim; B R Min; Y I Lee; Y K Kang
Journal:  Int J Cancer       Date:  1999-11-12       Impact factor: 7.396

Review 6.  Epidermal growth factor receptor signal transactivation.

Authors:  M Leserer; A Gschwind; A Ullrich
Journal:  IUBMB Life       Date:  2000-05       Impact factor: 3.885

7.  Regulation of cyclin-dependent kinase (Cdk) 2 Thr-160 phosphorylation and activity by mitogen-activated protein kinase in late G1 phase.

Authors:  M Chiariello; E Gomez; J S Gutkind
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

8.  A role for both Ets and C/EBP transcription factors and mRNA stabilization in the MAPK-dependent increase in p21 (Cip-1/WAF1/mda6) protein levels in primary hepatocytes.

Authors:  J S Park; L Qiao; D Gilfor; M Y Yang; P B Hylemon; C Benz; G Darlington; G Firestone; P B Fisher; P Dent
Journal:  Mol Biol Cell       Date:  2000-09       Impact factor: 4.138

9.  A c-fos/Estrogen receptor fusion protein promotes cell cycle progression and proliferation of human cancer cell lines.

Authors:  D L Crowe; T N Brown; R Kim; S M Smith; M K Lee
Journal:  Mol Cell Biol Res Commun       Date:  2000-04

Review 10.  Somatostatin receptor 1 (SSTR1)-mediated inhibition of cell proliferation correlates with the activation of the MAP kinase cascade: role of the phosphotyrosine phosphatase SHP-2.

Authors:  T Florio; S Thellung; S Arena; A Corsaro; A Bajetto; G Schettini; P J Stork
Journal:  J Physiol Paris       Date:  2000 May-Aug
View more
  4 in total

1.  Arecoline induces HA22T/VGH hepatoma cells to undergo anoikis - involvement of STAT3 and RhoA activation.

Authors:  Hsiao-Ling Cheng; Shu-Jem Su; Li-Wen Huang; Bau-Shan Hsieh; Yu-Chen Hu; Thu-Ching Hung; Kee-Lung Chang
Journal:  Mol Cancer       Date:  2010-05-28       Impact factor: 27.401

2.  Molecular mechanisms mediating the G protein-coupled receptor regulation of cell cycle progression.

Authors:  David C New; Yung H Wong
Journal:  J Mol Signal       Date:  2007-02-26

3.  Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation.

Authors:  Rodrigo R Resende; Avishek Adhikari
Journal:  Cell Commun Signal       Date:  2009-08-27       Impact factor: 5.712

4.  M2 Muscarinic acetylcholine receptor modulates rat airway smooth muscle cell proliferation.

Authors:  Fabiola A Placeres-Uray; Christopher A Febres-Aldana; Ruth Fernandez-Ruiz; Ramona Gonzalez de Alfonzo; Itala A Lippo de Becemberg; Marcelo J Alfonzo
Journal:  World Allergy Organ J       Date:  2013-12-30       Impact factor: 4.084

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.